Blueprint Medicines shares owned by Boothbay Fund Management
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Boothbay Fund Management
from 13F filings
Historical chart of Boothbay Fund Management investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Blueprint Medicines by Boothbay Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $34M | 387k | 88.51 |
| 2024-12-31 | $17M | 190k | 87.22 |
| 2024-09-30 | $2.3M | 25k | 92.50 |
| 2022-06-30 | $394k | 7.8k | 50.51 |
| 2022-03-31 | $498k | 7.8k | 63.85 |
| 2021-09-30 | $267k | 2.6k | 102.85 |
| 2021-06-30 | $262k | 3.0k | 88.07 |
| 2021-03-31 | $233k | 2.4k | 97.16 |
| 2020-06-30 | $1.9M | 24k | 78.00 |
| 2019-06-30 | $462k | 4.9k | 94.29 |
| 2019-03-31 | $489k | 6.1k | 80.11 |
| 2018-12-31 | $399k | 7.4k | 53.91 |
| 2018-09-30 | $455k | 5.8k | 78.14 |
| 2017-03-31 | $1.8M | 45k | 40.00 |